Epigenetic Regulation of the 'Peroxisome Proliferator Activating Receptor-Gamma' Gene in Acute Myeloid Leukemia Patients

被引：0
|
作者：
Sahin, Deniz Goren [1 ]
Gunduz, Eren [2 ]
Yurteri, Buket [3 ]
Yesilyurt, Ahmet [3 ]
Andic, Neslihan [2 ]
Teke, Hava Uskudar [2 ]
Akay, Olga Meltem [4 ]
机构：
[1] Demiroglu Bilim Univ, Dept Hematol, Istanbul, Turkey
[2] Eskisehir Osmangazi Univ, Dept Hematol, Med Fac, Eskisehir, Turkey
[3] Diskapi Training & Res Hosp, Dept Genet, Ankara, Turkey
[4] Koc Univ, Dept Hematol, Med Sch, Istanbul, Turkey
来源：
CLINICAL LYMPHOMA MYELOMA & LEUKEMIA | 2019年 / 19卷
关键词：
epigenetic; peroxisome proliferator activating receptor-gamma; acute myeloid leukemia; AML;
D O I：
10.1016/j.clml.2019.07.059
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
AML-030
引用
收藏
页码：S202 / S203
页数：2
相关论文
共 50 条
  • [21] Serum peroxisome proliferator-activated receptor-gamma levels in acute phase of male patients with schizophrenia and their relationship with metabolic parameters
    Kalelioglu, Tevfik
    Durak, Nurdan
    Karamustafalioglu, Nesrin
    Genc, Abdullah
    Akkus, Mustafa
    Tasdemir, Akif
    Ilnem, Cem Mehmet
    PSYCHIATRY AND CLINICAL PSYCHOPHARMACOLOGY, 2017, 27 (01) : 30 - 34
  • [22] Isorhamnetin Protects Against Pentylenetetrazole Kindled Seizures by Activating Peroxisome Proliferator-Activated Receptor-Gamma (PPARγ) in Mice
    Duan, Jiqiang
    Zhao, Jinan
    Sui, Long
    Liu, Yan
    LATIN AMERICAN JOURNAL OF PHARMACY, 2023, 42 (05): : 1118 - 1126
  • [23] Inhibition of peroxisome proliferator-activated receptor-gamma in myeloid lineage cells induces systemic inflammation, immunosuppression and tumorigenesis
    Du, Hong
    Wu, Lingyan
    Yan, Cong
    CANCER RESEARCH, 2011, 71
  • [24] Stimulation of Peroxisome Proliferator-Activated Receptor-Gamma (PPARγ) using Pioglitazone Decreases the Survival of Acute Promyelocytic Leukemia Cells through Up-Regulation of PTEN Expression
    Esmaeili, Shadi
    Safaroghli-Azar, Ava
    Pourbagheri-Sigaroodi, Atieh
    Salari, Sina
    Gharehbaghian, Ahmad
    Hamidpour, Mohsen
    Bashash, Davood
    ANTI-CANCER AGENTS IN MEDICINAL CHEMISTRY, 2021, 21 (01) : 108 - 119
  • [25] Clinical relevance of peroxisome proliferator-activated receptor-gamma expression in myxoid liposarcoma
    Akihiko Takeuchi
    Norio Yamamoto
    Toshiharu Shirai
    Katsuhiro Hayashi
    Shinji Miwa
    Seiichi Munesue
    Yasuhiko Yamamoto
    Hiroyuki Tsuchiya
    BMC Cancer, 16
  • [26] The Protective Role of Peroxisome Proliferator-Activated Receptor-Gamma in Seizure and Neuronal Excitotoxicity
    Te-Yu Hung
    Fang-Liang Chu
    Dong Chuan Wu
    Sheng-Nan Wu
    Chin-Wei Huang
    Molecular Neurobiology, 2019, 56 : 5497 - 5506
  • [27] Targeting the Peroxisome Proliferator-Activated Receptor-gamma to Counter the Inflammatory Milieu in Obesity
    Corzo, Cesar
    Griffin, Patrick R.
    DIABETES & METABOLISM JOURNAL, 2013, 37 (06) : 395 - 403
  • [28] Negative regulation of peroxisome proliferator-activated receptor-gamma gene expression contributes to the antiadipogenic effects of tumor necrosis factor-alpha
    Zhang, B
    Berger, J
    Hu, EI
    Szalkowski, D
    WhiteCarrington, S
    Spiegelman, BM
    Moller, DE
    MOLECULAR ENDOCRINOLOGY, 1996, 10 (11) : 1457 - 1466
  • [29] Retinoid X receptor and peroxisome proliferator-activated receptor-gamma agonists cooperate to inhibit matrix metalloproteinase gene expression
    Peter S Burrage
    Adam C Schmucker
    Yanqing Ren
    Michael B Sporn
    Constance E Brinckerhoff
    Arthritis Research & Therapy, 10
  • [30] Treating the metabolic syndrome: telmisartan as a peroxisome proliferator-activated receptor-gamma activator
    Kurtz, TW
    ACTA DIABETOLOGICA, 2005, 42 (Suppl 1) : S9 - S16
12345